EP0587775A4 - Induction of ctl responses to foreign antigens expressed in mycobacteria. - Google Patents
Induction of ctl responses to foreign antigens expressed in mycobacteria.Info
- Publication number
- EP0587775A4 EP0587775A4 EP9292913615A EP92913615A EP0587775A4 EP 0587775 A4 EP0587775 A4 EP 0587775A4 EP 9292913615 A EP9292913615 A EP 9292913615A EP 92913615 A EP92913615 A EP 92913615A EP 0587775 A4 EP0587775 A4 EP 0587775A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- mycobacteria
- induction
- ctl responses
- antigens expressed
- foreign antigens
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 230000006698 induction Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71164391A | 1991-06-06 | 1991-06-06 | |
US711643 | 1996-09-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0587775A1 EP0587775A1 (en) | 1994-03-23 |
EP0587775A4 true EP0587775A4 (en) | 1994-11-02 |
Family
ID=24858927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP9292913615A Withdrawn EP0587775A4 (en) | 1991-06-06 | 1992-06-01 | Induction of ctl responses to foreign antigens expressed in mycobacteria. |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0587775A4 (en) |
AU (1) | AU2185592A (en) |
CA (1) | CA2110682A1 (en) |
WO (1) | WO1992021376A1 (en) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08505625A (en) | 1993-01-11 | 1996-06-18 | ダナ−ファーバー キャンサー インスティチュート | Induction of cytotoxic T lymphocyte response |
US7300660B2 (en) | 1993-11-23 | 2007-11-27 | The Regents Of The University Of California | Abundant extracellular products and methods for their production and use |
US6752993B1 (en) | 1993-11-23 | 2004-06-22 | The Regents Of The University Of California | Abundant extracellular product vaccines and methods for their production and use |
CN1103781C (en) | 1993-11-23 | 2003-03-26 | 加利福尼亚大学 | Abundant extracellular products and methods for production and use of same |
GB9426153D0 (en) * | 1994-12-23 | 1995-02-22 | Medical Res Council | Improvements in or relating to vaccines |
US6013660A (en) * | 1996-10-02 | 2000-01-11 | The Regents Of The University Of California | Externally targeted prophylactic and chemotherapeutic method and agents |
EP1105490A1 (en) | 1998-08-20 | 2001-06-13 | Aventis Pasteur Limited | Nucleic acid molecules encoding inclusion membrane protein c of chlamydia |
US6686339B1 (en) | 1998-08-20 | 2004-02-03 | Aventis Pasteur Limited | Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia |
US6693087B1 (en) | 1998-08-20 | 2004-02-17 | Aventis Pasteur Limited | Nucleic acid molecules encoding POMP91A protein of Chlamydia |
CA2721011A1 (en) | 1999-10-22 | 2001-05-03 | Aventis Pasteur Limited | Modified gp100 and uses thereof |
EP1792995A3 (en) | 2000-05-08 | 2007-06-13 | Sanofi Pasteur Limited | Chlamydia secretory locus orf and uses thereof |
CA2408328C (en) | 2000-05-10 | 2012-04-17 | Aventis Pasteur Limited | Immunogenic polypeptides encoded by mage minigenes and uses thereof |
DE60127421T8 (en) | 2000-08-25 | 2008-08-28 | Chancellor, Masters And Scholars Of The University Of Oxford | INTERNAL CORE OLIGOSACCHARIDE EPITOPES FROM LIPOPOLYSACCHARIDES OF HAEMOPHILUS INFLUENZA AS VACCINES IN THE PROPHYLACTIC TREATMENT OF HAEMOPHILUS INFLUENZAE INFECTIONS |
AU2002211201B2 (en) | 2000-11-02 | 2007-05-31 | The National University Of Singapore | aopB Gene, protein, homologs, fragments and variants thereof, and their use for cell surface display |
AU2002364161A1 (en) | 2001-12-12 | 2003-06-23 | Aventis Pasteur Limited | Enhancement of the immune response using cd36-binding domain |
AU2003223527B2 (en) | 2002-04-09 | 2009-01-15 | Sanofi Pasteur Limited | Modified CEA nucleic acid and expression vectors |
MX2011006922A (en) | 2008-12-24 | 2012-06-12 | Netherlands Vaccine Inst | Modified steptococcus pneumonia pneumolysin (ply) polypeptides. |
EP2668201A2 (en) | 2011-01-28 | 2013-12-04 | Sanofi Pasteur SA | Immunological compositions comprising hiv gp41 polypeptide derivatives |
KR101663234B1 (en) * | 2011-04-18 | 2016-10-07 | 명지대학교 산학협력단 | Cyclic peptide from nonomuraea sp., process for the production thereof, and pharmaceutical composition for the prevention or treatment of mycobacteria related disease comprising the same |
AU2012294454B2 (en) | 2011-08-08 | 2017-02-02 | Curelab Oncology, Inc. | Methods and compositions relating to p62 for the treatment and prophylaxis of cancer |
EP2895501B1 (en) | 2012-09-17 | 2017-01-18 | Novartis Tiergesundheit AG | Salmonid alphavirus and uses thereof |
US9809863B2 (en) | 2012-11-02 | 2017-11-07 | Elanco Tiergesundheit Ag | Flavivirus associated with Theiler's disease |
WO2014140938A2 (en) | 2013-03-14 | 2014-09-18 | Centre Hospitalier Universitaire Vaudois | Immunological methods |
CN106061501A (en) | 2013-12-29 | 2016-10-26 | Cl昂科莱吉有限公司 | Methods and compositions relating to p62/sqstm1 for the treatment and prevention of inflammation-associated diseases |
PT3177644T (en) | 2014-08-05 | 2021-01-13 | MabQuest SA | Immunological reagents binding to pd-1 |
US10730933B2 (en) | 2015-12-05 | 2020-08-04 | Centre Hospitalier Universitaire Vaudois | HIV binding agents |
AU2017208819B2 (en) | 2016-01-22 | 2023-10-19 | MabQuest SA | PD1 specific antibodies |
WO2020012435A1 (en) | 2018-07-13 | 2020-01-16 | Lausanne University Hospital | Hiv binding agents |
EP3996815A2 (en) | 2019-07-15 | 2022-05-18 | Lausanne University Hospital | Hiv binding agents |
TW202206098A (en) | 2020-08-11 | 2022-02-16 | 美商碩騰服務公司 | Anti-coronavirus vaccines |
CN114315985A (en) | 2020-09-29 | 2022-04-12 | 硕腾服务有限责任公司 | Attenuated porcine epidemic diarrhea virus |
WO2023034804A1 (en) | 2021-08-31 | 2023-03-09 | Zoetis Services Llc | Attenuated alphavirus |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1988006626A1 (en) * | 1987-03-02 | 1988-09-07 | Whitehead Institute For Biomedical Research | Recombinant mycobacterial vaccine |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5504005A (en) * | 1987-03-02 | 1996-04-02 | Albert Einstein College Of Medicine Of Yeshiva University | Recombinant mycobacterial vaccine |
-
1992
- 1992-06-01 AU AU21855/92A patent/AU2185592A/en not_active Abandoned
- 1992-06-01 CA CA002110682A patent/CA2110682A1/en not_active Abandoned
- 1992-06-01 WO PCT/US1992/004538 patent/WO1992021376A1/en not_active Application Discontinuation
- 1992-06-01 EP EP9292913615A patent/EP0587775A4/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1988006626A1 (en) * | 1987-03-02 | 1988-09-07 | Whitehead Institute For Biomedical Research | Recombinant mycobacterial vaccine |
Non-Patent Citations (5)
Title |
---|
ANNA ALDOVINI ET AL.: "Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines", NATURE, vol. 351, no. 6326, 6 June 1991 (1991-06-06), LONDON GB, pages 479 - 482 * |
Annual meeting on modern approaches to new vaccines, 8th, Cold Spring Harbor, N. Y., September, 1990 * |
C.K. STOVER ET AL.: "New use of BCG for recombinant vaccines", NATURE, vol. 351, no. 6326, 6 June 1991 (1991-06-06), LONDON GB, pages 456 - 460 * |
See also references of WO9221376A1 * |
VIDAL F. DE LA CRUZ ET AL.: "Humoral and cellular immune responses to recombinant Mycobacteria (BCG)", VACCINES 91: MODERN APPROACHES TO NEW VACCINES INCLUDING PREVENTION OF AIDS, 1991, pages 399 - 402 * |
Also Published As
Publication number | Publication date |
---|---|
EP0587775A1 (en) | 1994-03-23 |
WO1992021376A1 (en) | 1992-12-10 |
AU2185592A (en) | 1993-01-08 |
CA2110682A1 (en) | 1992-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0587775A4 (en) | Induction of ctl responses to foreign antigens expressed in mycobacteria. | |
AP9200376A0 (en) | Novel antibodies and methods for their use | |
AU6886287A (en) | Varying firmness mattress | |
EP0746621A4 (en) | Expression of proteins on bacterial surface | |
DK99288A (en) | GRINDING TOPIC | |
OA09809A (en) | Mococlonal antibodies to ELAM-1 and their uses. | |
EP0599479A3 (en) | Lactobacillus used to enhance immunological functions. | |
GB9109435D0 (en) | Improvements in and relating to cookers | |
AU652970B2 (en) | Squamous cell carcinoma-like immunoreactive antigen from human female urine | |
AU8079187A (en) | Arrangement in connection with induction heating | |
EP0582672A4 (en) | Methods to detect and treat diseases caused by bacterial allergens | |
AU3166093A (en) | Induction heater | |
AU1308288A (en) | Method to stimulate the immune response to specific antigens | |
PL294075A1 (en) | Gelly preparations dispersible in water | |
GB9126932D0 (en) | Improvements in and relating to cookers | |
AU1481088A (en) | Hot runner device | |
AU2151092A (en) | Vaccines with erythrocytes as antigen carriers | |
GB2214509B (en) | Human monoclonal antibody to p.aeruginosa and gram negative bacteria: its production and use | |
ZA926340B (en) | Induction of CTL responses | |
ZA887732B (en) | Bacterial strain | |
JPS55125712A (en) | Suerlow electric delay line utilizing thin film inductor array by magnetic lift and coupling | |
EP0587765A4 (en) | Induction of immune response against tetanus toxin through administration of mycobacteria expressing tetanus toxin or fragments. | |
AU1421492A (en) | Ovine adipocyte antigens and their use in the immunological control of fat | |
Marshall | Responses to lactation | |
HUT48446A (en) | Coffee mill |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19940104 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19940916 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE |
|
18W | Application withdrawn |
Withdrawal date: 19941021 |